MobiHealth News June 30, 2023
Also, Augnito unveils its ambient technology for clinical documentation.
Medical IP gets US FDA nod for AI body composition analysis software
South Korean medical imaging company Medical IP has obtained a United States Food and Drug Administration 510(k) clearance for its AI-powered body composition analysis software.
According to the company, DeepCatch is the first FDA-approved AI software that automatically analyses body components, such as skin, bone, muscle, visceral fat, subcutaneous fat, internal organ, and central nervous system, through whole-body CT. It provides reports with 3D visual and quantitative information.
With this FDA clearance, Medical IP will be accelerating its plan to expand globally.
Augnito launches ambient tech for clinical documentation
Indian health tech company Augnito has introduced...
Today's Sponsors
Today's Sponsor